ClinicalTrials.Veeva

Menu
A

Alea Research | Phoenix, AZ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rapastinel
Pilocarpine
BI 409306
Balovaptan
EYE103
Troriluzole
Troriluzule
Atogepant
Liafensine
Dihydroergotamine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 17 total trials
Locations recently updated

A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (ARISE)

This is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with schizophrenia with an inadequ...

Enrolling
Schizophrenia
Drug: Xanomeline and Trospium Chloride Capsules
Drug: Placebo

The study's purpose its to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compu...

Enrolling
Obsessive-Compulsive Disorder
Drug: Troriluzole
Drug: Placebo

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only
Obsessive Compulsive Disorder
Drug: Troriluzole (BHV-4157)

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and so...

Active, not recruiting
Episodic Migraine
Drug: Placebo
Drug: BOTOX

Trial sponsors

AbbVie logo
Allergan logo
Biohaven logo
Allergan logo
Boehringer Ingelheim logo
D
E
G
Karuna Therapeutics logo
Ocuphire Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems